Task: Question Generation
Input (English): Essentials Platelet-Factor (F) VIII gene therapy is a promising treatment in hemophilia A. This study aims to evaluate if platelet-FVIII expression would increase the risk for thrombosis. Targeting FVIII expression to platelets does not induce or elevate thrombosis risk. Platelets expressing FVIII are neither hyper-activated nor hyper-responsive.
Output (English): Does targeting factor VIII expression to platelets for hemophilia A gene therapy induce an apparent thrombotic risk in mice?